Clinical trial
Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma
NCT00145639 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00145639 |
|---|---|
| Title | Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma |
| Official title | Osteosarcoma 1999-A Study Of Intensive Chemotherapy Utilizing Ifosfamide, Carboplatin, and Doxorubicin for Adjuvant Chemotherapy for Treatment of Osteosarcoma |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | Immunex/Berlex Industry National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteosarcoma |
| Intervention type | Drug, Procedure |
| Interventions | Ifosfamide, Carboplatin, Doxorubicin, Limb Sparing |
| Enrollment | 80 |
| Start date | May 1, 1999 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 5, 2005 |
| Last update posted | Jun 10, 2011 |
| Countries | Chile, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: